11/15/2011 3:57 PM 

U.S. Sens. Mark Pryor (D-AR) and John Boozman (R-AR) today questioned Federal Trade Commission (FTC) nominees about scrutiny of the proposed Express Scripts and Medco merger.  The Senators asked their questions as part of a Senate Commerce, Science & Transportation Committee hearing on the re-nomination of FTC Chairman Jon Leibowitz and the nomination of Maureen Ohlhausen to become a Commissioner. 

The Senators expressed concerns about the magnitude and effects of the merger, with Sen. Boozman mentioning specifically the importance of community pharmacy and fears surrounding the ability of a large merged entity to push patients to mail order.